Invivo inhibition of ALR2 in STZ-induced diabetic Sprague-Dawley rat model assessed as reduction in ALR2 activity in lens at 80 mg/kg, IG administered...

Basic Information

ID: ALA5148739

Type: Functional

Description: Invivo inhibition of ALR2 in STZ-induced diabetic Sprague-Dawley rat model assessed as reduction in ALR2 activity in lens at 80 mg/kg, IG administered once daily for 28 days relative to control

Format: BAO_0000218

Organism: Rattus norvegicus

Strain: Sprague-Dawley

Target: Unchecked(ALA612545)

Document: ALA5143721

Invivo inhibition of ALR2 in STZ-induced diabetic Sprague-Dawley rat model assessed as reduction in ALR2 activity in lens at 80 mg/kg, IG administered once daily for 28 days relative to control: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA5148739

Activity

Total(2)

Parent Molecular Weight	ALogP	Polar Surface Area
319.41	2.92	2.92
369.33	2.07	2.07

Parent Molecular Weight

ALogP

Polar Surface Area

319.41

2.92

369.33

2.07

Invivo inhibition of ALR2 in STZ-induced diabetic Sprague-Dawley rat model assessed as reduction in ALR2 activity in lens at 80 mg/kg, IG administered...

Basic Information

Activity Charts

Compound Summary